Prescient Therapeutics (ASX:PTX) - TechKnow Invest Roadshow, August 2023

16/08/2023 09:14:00

This video is not supported on your device. Click here for the original version.

Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.